Keynote, Invited and Guest Speakers for 2025
The BAD Conference & Events Committee is extremely grateful to the contribution of the Keynote, Invited and Guest lecturers that attend the BAD Annual Meeting speaking in the Plenary and concurrent sessions. Some are familiar BAD Members, whilst others are from outside both the association and the specialty. All offer an invaluable educational benefit to our members and we are very thankful.
Details will appear here shortly on the Keynote and Invited Lecturers for the 2025 Annual Meeting.
Tuesday 1 July – Plenary Speakers
Professor John A. Rogers obtained BA and BS degrees in chemistry and in physics from the University of Texas, Austin, in 1989. From MIT, he received SM degrees in physics and in chemistry in 1992 and a PhD degree in physical chemistry in 1995. From 1995 to 1997, Rogers was a Junior Fellow in the Harvard University Society of Fellows. He joined Bell Laboratories as a Member of Technical Staff in 1997 and then served as Director of the Condensed Matter Physics Research Department from the end of 2000 to 2002. He then spent thirteen years on the faculty at the University of Illinois, most recently as the Swanlund Chair Professor and Director of the Seitz Materials Research Laboratory. In the Fall of 2016, he moved to Northwestern University where he is Director of the recently endowed Querrey-Simpson Institute for Bioelectronics. He has co-authored nearly 1000 papers and he is co-inventor on more than 100 patents, more than 70 or which are licensed to large companies or to startups that have emerged from his labs. His research has been recognized by many awards, including a MacArthur Fellowship (2009), the Lemelson-MIT Prize (2011), the Smithsonian Award for American Ingenuity in the Physical Sciences (2013), the MRS Medal (2018), the Benjamin Franklin Medal from the Franklin Institute (2019), a Guggenheim Fellowship (2021), the James Prize for Science and Technology Integration from the NAS (2022) and the IEEE Biomedical Engineering Award (2024). He is a member of the National Academy of Engineering, the National Academy of Sciences, the National Academy of Medicine, the National Academy of Inventors and the American Academy of Arts and Sciences.
Your Content Goes Here
Graduated in Medicine from Monash University with Honours in 1993
Two years of training as Clinical Research Fellow at Dept of Dermatology, Churchill Hospital, Oxford.
Obtained Fellowship of Australasian College of Dermatologists in 2004
Visiting Dermatologist at the Victorian Melanoma Service, Paula Fox Melanoma and Cancer Centre, Alfred Health, Melbourne since 2005
Authored over 70 publications & co-editor of textbook “Diagnostic Dermoscopy: The Illustrated Guide” (Bowling, Paoli & Chamberlain) 2nd Edition published in 2022
Adjunct Associate Professor, School of Translational Medicine, Monash University
Previous Assistant Editor, Australasian Journal of Dermatology
National Examinations Committee, Australasian College of Dermatologists
Wednesday 2 July – Plenary Speakers
Dr Ashley Wysong is Professor Emeritus and Founding Chair at the University of Nebraska Department of Dermatology. She is an accomplished leader, an internationally recognized Mohs micrographic surgeon, a translational skin cancer researcher, and a dedicated mentor. Dr Wysong obtained her master’s degree in epidemiology at Stanford University and her medical degree at Duke University School of Medicine where she was valedictorian. She completed her residency in dermatology at Stanford University where she was chief resident and her fellowship in Mohs micrographic surgery and Cutaneous Oncology at Scripps Clinic. Dr. Wysong has a broad background in clinical, translational, and outcomes-based research in squamous cell carcinoma and other high-risk skin cancers.
Hayley is a Consultant Dermatologist & Dermatological Surgeon at the Royal Free NHS Trust in Hampstead, London. Hayley has expertise in early detection of Skin cancer, Mohs surgery and Cosmetic dermatology. She is Secretary of the BCDG and co-director of the national Injectables course with a passion for improving cosmetic training for dermatologists in the UK. Hayley has undertaken numerous procedural fellowships internationally including the Netherlands & the USA.
Dr Aveen Connolly is a UK-trained consultant dermatologist. She completed her dermatology training at St John’s Institute of Dermatology within Guy’s and St Thomas’ and King’s College Hospital, London, and currently practices between the Royal Free and King’s College Hospitals in London.
Dr Connolly’s primary research interests focus on connective tissue diseases involving the skin and hair, including lupus, dermatomyositis, and scleroderma. She was awarded the prestigious Louis Forman Fellowship by the Royal Society of Medicine and the British Skin Foundation, which she successfully completed with rheumatology, in 2023. Dr Connolly is also actively involved in several clinical trials at King’s College Hospital, with a focus on connective tissue diseases.
She has published extensively and presented at both national and international conferences, earning numerous accolades for her work. A passionate advocate for medical education, Dr Connolly serves as the Associate Editor for Clinical and Experimental Dermatology (CED).
Your Content Goes Here
Your Content Goes Here
Your Content Goes Here
Dr Helen Lotery MD FRCP FRCPI MRCGP is a consultant dermatologist in Southampton with particular interest in vulval dermatology and in medical education.
After initially training as a GP in Northern Ireland, she spent 3 years in a clinical and research fellowship in vulval disease at the University of Iowa. She moved to Southampton in 2002, trained in dermatology on the Wessex SpR rotation and has been a consultant in University Hospital Southampton NHS Foundation Trust since 2007 and an Honorary Principal Teaching Fellow at the University of Southampton. She leads the multidisciplinary vulval service, and the vulva remains her chosen specialised subject.
Thursday 3 July – Plenary Speakers
James L. Kirkland, M.D., Ph.D., is Director of the Center for Advanced Gerotherapeutics at Cedars-Sinai Medical Center, Los Angeles and Emeritus Professor of Medicine at Mayo Clinic, Rochester, Minnesota. Dr. Kirkland’s research is on the contribution of aging processes, particularly cellular senescence, to multiple disorders and diseases across the lifespan and development of gerotherapeutics: agents and strategies for targeting these aging mechanisms to delay, prevent, alleviate, or treat the conditions that cause the bulk of disability, mortality, and health expenditures across the developed and developing world. Dr. Kirkland discovered senolytic drugs, agents that selectively eliminate senescent cells. Dr. Kirkland and then others demonstrated that senolytic agents enhance healthspan and treat multiple diseases in animal models, human cells, and tissue explants. He published the first composite biomarker gerodiagnostic score of senescent cell burden that is sensitive to drug interventions in humans and the first clinical trials of senolytic drugs. He is preparing or conducting clinical studies of senolytics, including for infections, frailty, Alzheimer’s disease, diabetes/obesity, osteoporosis, cancer survivors, idiopathic pulmonary fibrosis, pre-eclampsia, glioblastoma, complications of space travel, agricultural applications, restoring function of organs from old donors to enable their use for transplantation, and others. He has more than 330 publications (H index: 110) and holds 24 patents. Dr. Kirkland is Principal Investigator of the National Institutes of Health Translational Geroscience Network (R33 AG061456), which brings together academic institutions across the US to translate healthspan interventions, including senolytics and other drugs that target fundamental aging processes, from bench to bedside, and is currently involved in over 85 interventional and observational clinical trials. He is President-Elect of the Healthy Longevity Medicine Society, immediate past President of the American Federation for Aging Research, a past member of the National Advisory Council on Aging of the National Institutes of Health, past chair of the Biological Sciences Section of the Gerontological Society of America, and past member of the Clinical Trials Advisory Panel of the National Institute on Aging. He is a board-certified specialist in internal medicine, geriatrics, and endocrinology and metabolism. Dr. Kirkland is the 2020 recipient of the Irving S. Wright Award of Distinction from the American Federation for Aging Research.
David Bick MD is the Principal Clinician for the Newborn Genomes Programme at Genomics England. Prior to his work in England, he was the Chief Medical Officer and a faculty investigator at the HudsonAlpha Institute for Biotechnology. Dr. Bick also served as the Medical Director of the Smith Family Clinic for Genomic Medicine at HudsonAlpha and the Laboratory Director of the HudsonAlpha Clinical Services Laboratory.
He came to HudsonAlpha from the Medical College of Wisconsin where he was Professor in the Department of Pediatrics and the Department of Obstetrics & Gynecology and Director of the Clinical Sequencing Laboratory, Director of the Advanced Genomics Laboratory, Medical Director of the Genetics Clinic at Children’s Hospital of Wisconsin, and Chief of the Division of Genetics in the Department of Pediatrics at Medical College of Wisconsin. Dr. Bick is board certified in Pediatrics, Clinical Genetics, and Clinical Molecular Genetics.
Dr. Bick has published numerous peer-reviewed articles, chapters, and reviews. His laboratories at the Medical College of Wisconsin and Children’s Hospital of Wisconsin were the first in the world to offer whole genome sequencing as a clinical test. He also developed the first Genomic Medicine Clinic in the United States.
John McGrath is the academic head of St John’s Institute of Dermatology in London where he also runs the Genetic Skin Disease Group. He holds the Mary Dunhill Chair in Cutaneous Medicine at King’s College London and is Honorary Consultant Dermatologist to the Guy’s and St Thomas’ National Health Service Foundation Trust. He is also currently a Yu-Shan Fellow at the National Cheng Kung University in Tainan (Taiwan). His expertise is in genodermatoses, discovering genes and testing experimental therapies to improve patient care. He has held several leadership positions within European dermatology including serving as President for the European Society for Dermatological Research and the European Dermatology Forum. He has published >600 articles and is the current editor-in-chief of the British Journal of Dermatology (2024-2029).
Dr Aaron Wernham is a Consultant Dermatologist and Mohs surgeon at Walsall Healthcare NHS Trust and The Royal Wolverhampton Hospitals NHS Trust. He is a past UKDCTN trainee fellow and now a member of the steering committee for the UK Dermatology Clinical Trials Network (UKDCTN) and a UKDCTN trainee mentor. He co-led a Priority Setting Partnership in skin cancer surgery and the CANVAS suture study, and is a trial team member for the NIHR HTA funded EXCISE study. He is also co-Chief Investigator for NIHR HTA funded HEALS2 study.
Catherine is a NIHR Senior Investigator, Professor of Dermatology and Therapeutics, and Consultant Dermatologist at St John’s Institute of Dermatology. She leads the Skin Health theme at the Kings Health Partners Centre for Translational Medicine, and National specialised services for adults with severe psoriasis and eczema. Her clinical and research interests focus on inflammatory skin disease with the overall aim of determining when, and how best, to intervene.
Tuesday 1 July – Special Interest Group Speakers
Joint BAD/BSD Neil Smith Lecture
Mycosis fungoides immunophenotypic variants
Prof Emilio Berti (Milan, Italy)
Guest speaker
Aggressive primary cutaneous T-cell lymphomas: alpha/beta and gamma-delta
Prof Emilio Berti (Milan, Italy)
Guest Speaker:
‘Transformative Updates in Skin Cancer Care for Immunosuppressed Patients’
Dr Ashley Wysong (Omaha, United States)
Prosser-White Oration
Prof Margarida Gonçalo
Clinical perspective on cutaneous drug allergy
Secretary General elected of the European Academy of Dermatology and Venereology (EADV), Sub-Director of the Faculty of Medicine, University of Coimbra (FMUC) (since 2024), Invited Professor of Dermatology, FMUC (since 2015), with Aggregation in 2022.
Chair of the Dermatology Department, University Hospital of Coimbra, Local Health Unit of Coimbra, E.P.E. (since 2022), responsible for the unit of Cutaneous Allergy and the GA2LEN Urticaria and Angioedema Center of Reference and Excellence (UCARE and ACARE) and the consultations of Atopic Dermatitis, Chronic Urticaria and Immuno-inflammatory skin diseases, including Cutaneous Lupus Erythematosus.
Session Editor of Contact Dermatitis and Journal of the EADV (until dec 2023), Editor-in-Chief of the Journal of the Portuguese Society of Dermatology.
Author/co-author of 25 book chapters, >300 papers in peer-reviewed journals mostly on contact dermatitis, drug eruptions, urticaria, atopic dermatitis and other immune mediated skin diseases and more than 300 invited lectures.
Guest Lecture
Dr Louise Savic (Leeds)
Chlorhexidine Allergy
Guest Speaker:
- Cultural Practices and Ethical Challenges in Dermatology: A Global Perspective
Dr Antoine Petit (Paris, France)
Dr Louise Savic (Leeds)
Penicillin Delabelling
Dr Chris Rutkowski (London)
Excipient Allergy
Dr Ying Teo (Southampton)
The value of patch testing to find the cause of drug allergy reaction
Dr Ashley Wysong
Dr Ashley Wysong is Professor Emeritus and Founding Chair at the University of Nebraska Department of Dermatology. She is an accomplished leader, an internationally recognized Mohs micrographic surgeon, a translational skin cancer researcher, and a dedicated mentor. Dr Wysong obtained her master’s degree in epidemiology at Stanford University and her medical degree at Duke University School of Medicine where she was valedictorian. She completed her residency in dermatology at Stanford University where she was chief resident and her fellowship in Mohs micrographic surgery and Cutaneous Oncology at Scripps Clinic. Dr. Wysong has a broad background in clinical, translational, and outcomes-based research in squamous cell carcinoma and other high-risk skin cancers.
Guest Lecture
Learning about learning: can we improve medical student placements?
Dr Ana Sergio Da Silva (Swansea)
Wednesday 2 July – Special Interest Group Speakers
Dr Helen Hanson
Dr Helen Hanson is a Consultant in Cancer Genetics at the Peninsula Regional Genetics Service at the Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK and holds an NIHR Senior Investigator Fellowship at the Exeter NIHR Biomedical Research Centre.
Dr Hanson qualified in medicine in 2002 from Guy’s, Kings and St Thomas’ Medical School, London and became a member of the Royal College of Physicians in 2005 and a Fellow in 2017. She completed her Clinical Genetics Training at St. George’s Hospital and Guy’s Hospital and has previously been a Consultant at the Royal Marsden and St. George’s Hospital in London, before taking up her current post in September 2023.
Dr Hanson is the outgoing Chair of the UK Cancer Genetics Group and has a strong clinical and research interest in improving the diagnosis and management of individuals with an inherited predisposition to cancer. She has collaborated nationally and internationally in the development of clinical guidelines for individuals with inherited cancer predisposition, including BAP1 and POT1, set up a National Cancer Genetics MDT and led development and implementation of a National Inherited Cancer Predisposition Register in England.
Dr Cristina Galván-Casas
Dermatologist PhD,, especially dedicated to infectious, neglected and emerging diseases, mainly COVID-19, mpox and scabies.
She has worked in Spain as a dermatologist at the Hospital Universitario de Móstoles, as a researcher at the Fight Infections Foundation and as a professor at the Universidad Rey Juan Carlos.
She is founder of the DerMalawi project. She has extensive experience in community projects of integrated dermatology and teledermatology in rural areas of Africa and refugee camps in the Sahara.
She is currently vice-president of the International Alliance for Scabies Control (IACS), president of the Solidarity Dermatology unit of the Spanish Academy of Dermatology (AEDV), and an active collaborator in several WHO working groups related to neglected skin diseases, and in the Migrant Health Working Group (MHWG) of the International Foundation of Dermatology (IFD), where she is in charge of Capacity Building programmes.
Invited Talk
Dermatitis Artefacta- history and psychopathology
Prof Femi Oyebode (Birmingham)
| Invited Talk
A History of Dermatology in Glasgow and the West of Scotland Prior to 1980 Prof Rona Mackie (Glasgow) |
Thursday 3 July – Special Interest Group Speakers
